T
The startup develops therapeutics for glioblastoma multiforme using artificial intelligence algorithms to identify relationships between calcium channels and small molecules with established anti-cancer properties. This approach provides clinical candidates for various oncological indications, enhancing treatment options for patients facing this aggressive cancer.
Updated 3 months ago
Funding
$3.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops therapeutics for glioblastoma multiforme using artificial intelligence algorithms to identify relationships between calcium channels and small molecules with established anti-cancer properties. This approach provides clinical candidates for various oncological indications, enhancing treatment options for patients facing this aggressive cancer.